Arevna Insourcing

The RTT statistics in Cancer Care state there is an increase in patients waiting to be seen and diagnoses. Levels of urgent suspected Cancer referrals hit a new record in March 2024, with the 12,554 patients seen per working day a new record high, exceeding the previous record of 12,376 patients seen per working day in July 2023. This is 33% more referrals than the NHS was seeing before the pandemic – the equivalent of 3,000 more patients per working day.

Arevna Insourcing work to a 5 step solution

Consult

We will review current processes and pressure points and then review potential options available

Collaborate

We will work as an extended part of your department to optimise each service and find solutions which will fit patient and departmental needs

Co-operate

We understand each service has needs to deliver under constraints, thus we will ensure we prioritise based around these strain

Complete

We will deliver the solution(s) within allocated time and budgets to reduce RTT and ensure paramount patient safety and satisfaction

Compliance

Working within a strict Clinical Governance framework we will ensure that compliance is at the forefront of each service we provide

Are you finding it challenging to manage the growing pressures in your Cancer Care department to meet rising patient demand?

With the UK’s aging population and rising healthcare demands, there is over 12,500 patients being seen daily in the NHS, placing immense pressure on departments to meet 18-week targets and deliver essential care. It is evident that the strain on services is growing as they strive to meet these critical demands.

Our tailored insourcing solutions are designed to substantially reduce RTT waiting times while maintaining the highest standards of quality and safety. Our specialist teams collaborate closely with you to understand your unique service challenges, crafting a bespoke delivery model that aligns with your targets and operational needs.

Customised for you, organised by us

Haematology

Histopathology

Immunology

Microbiology

Oncology

At Arevna Insourcing, our pathology diagnostic treatments are at the forefront of precision medicine, playing a crucial role in accurately identifying and managing a wide range of diseases and conditions. We offer comprehensive laboratory services, including blood tests, biopsies, and cutting-edge molecular testing, essential for diagnosing cancers, infections, and genetic disorders. Utilising advanced technologies like immunohistochemistry, PCR (polymerase chain reaction), and next-generation sequencing, we ensure precise and reliable diagnostic results. Our services are designed to seamlessly integrate into clinical care pathways, assisting healthcare providers in selecting the most effective treatment options, monitoring disease progression, and achieving optimal patient outcomes. At Arevna Insourcing, we are committed to delivering timely and equitable access to our diagnostic services, ensuring that every patient receives accurate and personalised care.

Advantages of using Arevna Insourcing:

  • Reduced Waiting Times: Insourcing helps to alleviate patient backlogs and reduce waiting times for treatments and consultations.
  • Cost Efficiency: Utilising existing NHS facilities and resources can be more cost-effective than outsourcing to external providers.
  • Improved Quality Control: Insourcing allows for better oversight and adherence to high standards of care, ensuring consistent quality.
  • Enhanced Flexibility: Insourcing provides the flexibility to quickly adapt to changing demands and patient needs.
  • Increased Capacity: By using spare capacity within NHS facilities, insourcing can increase the number of patients treated without the need for additional infrastructure.
  • Better Staff Utilisation: Insourcing allows for the optimal use of NHS staff, including consultants and medical teams, to meet patient demand.
  • Patient Satisfaction: With reduced waiting times and improved quality of care, patient satisfaction rates are likely to increase.
  • Knowledge Sharing: Insourcing can facilitate the sharing of expertise and best practices among NHS staff, leading to overall improvements in service delivery.
  • Operational Control: Insourcing provides greater control over operations, allowing for better management and coordination of services.
  • Compliance and Safety: Ensuring that all procedures and treatments are carried out within NHS guidelines and regulations, maintaining high safety standards.
  • Approved supplier: NHS Supplier of major Frameworks
  • Nationwide coverage
  • Patient Centric: Full patient pathway – patient referral, consultations, diagnostics, follow up and discharge.
  • Lead by Specialists: Lead by NHS consultants
  • Scalable: Ability to scale up and down depending on demand

We understand the critical importance of adhering to your local service protocols, policies, and processes. Whether you opt for an insourced or outsourced solution, we are fully equipped to integrate seamlessly into your existing operations, working in close collaboration as an extension of your Pathology department.